Clinical Trial Update: Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

View source ↗

Summary

A retrospective study update examining pediatric Hemophilia A patients in China treated with regular prophylaxis containing recombinant Factor VIII.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Kovaltry (octocog alfa)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: COMPLETED